PKTX OTC
ProtoKinetix, Incorporated
1W: +0.0%
1M: -0.0%
3M: -96.2%
YTD: -96.9%
1Y: -96.4%
3Y: -99.3%
5Y: -99.8%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Smart Money Score
No convergence signal
Key Statistics
Market Cap$0.1M
52W Range0.000099999997-0.0124
Volume2,962
Avg Volume94,323
Beta0.73
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOMichael Richard Guzzetta
Employees5
SectorHealthcare
IndustryBiotechnology
IPO Date2002-04-22
Websiteprotokinetix.com
109 W Main St
Dalton, OH 44618
US
Dalton, OH 44618
US
740 434 5041
About ProtoKinetix, Incorporated
ProtoKinetix, Incorporated is a biotechnology firm engaged in research and development, specializing in the scientific and medical investigation of glycoproteins known as anti-freeze glycoproteins (AFGPs) and anti-aging glycoproteins (AAGPs). These AFGPs are particularly relevant for their commercial potential within the healthcare sector, with a key area of their development involving utilizing AAGPs for the treatment of dry-eye conditions. Their research efforts are bolstered by a collaborative agreement with the University of British Columbia. Originally incorporated in 1999 as RJV Network, Inc., the company adopted its current name, ProtoKinetix, Incorporated, in July 2003. Its operational headquarters are situated in Marietta, Ohio.
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Lamp Jason G. | 0 | — | 2026-06-17 | |
| Brunt Keith R. | 0 | — | 2026-06-17 | |
| Brunt Keith R. | 0 | — | 2026-06-17 | |
| Brunt Keith R. | 2,750,000 | $0.01 | 2026-06-17 | |
| Jones Michael Winsto | 0 | — | 2026-06-17 |